Quit Genius is a digital clinic for treating nicotine, alcohol, and opioid addictions.
Quit Genius is the world’s first digital clinic for treating nicotine, alcohol and opioid addictions. Built on the evidence-based approach of Medication-Assisted Treatment (MAT), Quit Genius combines virtual cognitive behavioral therapy (CBT) with approved medication and connected devices to help employers and health plans tackle the high cost of addiction, while improving the lives of their employees and members.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 19, 2021 | Series B | $64M | 1 | — | — | Detail |
Mar 18, 2020 | Series A | $12M | 1 |
![]() |
— | Detail |
May 22, 2018 | Seed | $2.60M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
— | Series B |
![]() |
— | Seed |